Navigation Links
Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland
Date:10/3/2007

Key Presentation by Dr. Yawei Ni, DelSite's CSO, Will Detail Antigen

Sparing and Immunoenhancing Attributes of GelSite(R) Polymer

IRVING, Texas, Oct. 3 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) today announced that Dr. Yawei Ni, Chief Scientific Officer of DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, will make an key presentation titled "An Effective Adjuvant Based on a Novel In-situ Gelling Anionic Polysaccharide (GelSite(R) Polymer)" on November 13, 2007, at the second International Conference on Modern Vaccines/Adjuvants Formulation (MVAF) in Dublin, Ireland.

GelSite(R) polymer is a chemically and functionally distinct polygalacturonic acid (sodium salt) produced under cGMP to a purity of > 99%. It is uniquely capable of gelling in-situ at the administration site upon contact with body fluids at low polymer concentrations providing a sustained release mechanism of the active component. It is highly suited for the delivery of vaccines and therapeutics.

The presentation will discuss details of GelSite(R) polymer's immunoenhancing and antigen sparing effect following intramuscular injection. The GelSite(R) polymer is inert and non-immunostimulatory, but achieves its immunoenhancing and antigen-sparing effect through sustained release of vaccine antigens conferred by the in-situ gelation. It potentially represents a new class of adjuvants that act through the sustained release mechanism, rather than by immunostimulation.

Vaccines, one of the fast growing pharmaceutical segments, are projected to account for greater than $20 billion in sales in the next few years. Adjuvants are a critical component for vaccine development. Vaccines in a wide range of areas including infectious diseases and cancers are being developed by various companies, many of which will require adjuvants for optimal performance.

About MVAF 2007

MVAF 2007 will be an international forum fo
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Researchers Present Ways To Reduce The Risk Of Dementia
4. Researchers Present Data Regarding The Efficiency Of Herbs
5. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
6. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
7. Drug Reactions First Present Themselves In The Mouth
8. Reminiscing Into The Past Makes You Dissatisfied With The Present
9. Living In The Past Indicates Dissatisfaction With Present
10. Movies Represent Coma In A Wrong Way
11. Onchocerciasis: Presentation And Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 28, 2015 , ... For Dallas, the time is nearing for the annual ... Tenet Health. , The American Heart Association hosts their well-known Heart Walk to raise ... together, a difference can be made. Walkers can participate in the cause and someone ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... As ... from Merz, received FDA clearance for results that last for two years, the ... exciting news for patients who are looking for a long-lasting, effective solution for their ...
(Date:8/28/2015)... , ... August 28, 2015 , ... On May 30th, ... joined as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. ... event was to raise money to support music education programs in the underfunded local ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL ... with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 ... 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the ... and data center assets and audio-video devices, recently released Visio Stencils for the ... HP ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
... , , BOTHELL, Wash., Sept. ... ) announced today that on September 15, 2009, the NYSE ... with respect to its previously disclosed listing deficiency as set ... Such deficiency relates to the Company,s failure to maintain stockholder,s ...
... SOMERSET, N.J., Sept. 18 TeamStaff, Inc. ... healthcare and administrative staffing services, today announced that on September ... Department of The Nasdaq Global Market (Nasdaq) stating that for ... has not maintained a minimum market value of publicly held ...
... , CHICAGO, Sept. 18 As economic, ... in Illinois, the state,s leading provider of addiction treatment services ... people who can,t afford expensive clinics but also fail to ... Gateway Foundation Inc., a 41-year-old non-profit organization, serves more than ...
... stems from access to alcohol or feelings of isolation remains ... study suggests there,s a link between suicide and rural communities ... research doesn,t confirm that more bars mean more suicides because ... those who commit suicide, about 20 percent are alcoholics, according ...
... SAN FRANCISCO, Sept. 18 VIA Pharmaceuticals, Inc. ... the development of compounds for the treatment of cardiovascular and ... received a deficiency letter from the NASDAQ Stock Market stating ... $1.00 per share bid price requirement for continued listing, as ...
... , , BROOMFIELD, Colo., Sept. 18 Accera, ... diseases, today announced today that it will present at the UBS ... , , Steve Orndorff, Ph.D., founder, president and ... on Axona (TM) on Monday, September 21 at 11:30 a.m. ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Health News:TeamStaff Receives Nasdaq Deficiency Notice Related to the Market Value of Its Publicly Held Shares 2Health News:TeamStaff Receives Nasdaq Deficiency Notice Related to the Market Value of Its Publicly Held Shares 3Health News:Gateway Responding To Increased Need for Treatment Among Middle-Income Substance Abusers 2Health News:Suicides Higher in Rural Areas With Bars 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 3Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 4Health News:Accera, Inc. to Present at UBS Global Life Sciences Conference 2
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... -- IP Shakti, LLC, today announced that it has changed its ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... signifies our transformation into a company focused on patent claim ... claim validity." ... platform, the Company commenced a corporate re-branding initiative in order ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
Inquire...
Inquire...
Inquire...
... Optimal for Subcellular Fractionation, Proteins ... g (30,000 rpm) with fixed-angle ... 0.25 up to 85 mL ... C to 40° C • ...
Medicine Products: